Genetic/familial high-risk assessment: Breast and ovarian - Clinical practice guidelines in oncology™

Mary B. Daly, Jennifer E. Axilbund, Saundra Buys, Beth Crawford, Carolyn D. Farrell, Susan Friedman, Judy E. Garber, Salil Goorha, Stephen B. Gruber, Heather Hampel, Virginia Kaklamani, Wendy Kohlmann, Allison Kurian, Jennifer Litton, P. Kelly Marcom, Robert Nussbaum, Kenneth Offit, Tuya Pal, Boris Pasche, Robert PilarskiGwen Reiser, Kristen Mahoney Shannon, Jeffrey R. Smith, Elizabeth Swisher, Jeffrey N. Weitzel

Research output: Contribution to journalArticle

Abstract

All cancers develop as a result of mutations in certain genes, such as those involved in the regulation of cell growth and/or DNA repair, but not all mutations are inherited. However, family studies have long documented an increased risk for several forms of cancer among first and second-degree relatives . Hereditary cancers are often characterized by mutations associated with a high probability of cancer development, vertical transmission through either mother or father, and an association with other types of tumors. They often have an early age of onset and exhibit an autosomal dominant inheritance pattern. Familial cancers share only some features of hereditary cancers. Although other cancers are associated with these hereditary syndromes, these guidelines mainly focus on management of breast and ovarian cancer risk in these individuals.

Original languageEnglish (US)
Pages (from-to)562-594
Number of pages33
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume8
Issue number5
StatePublished - May 2010
Externally publishedYes

Fingerprint

Practice Guidelines
Breast
Neoplasms
Mutation
Inheritance Patterns
Age of Onset
Fathers
DNA Repair
Ovarian Neoplasms
Mothers
Guidelines
Breast Neoplasms
Growth
Genes

Keywords

  • BRCA1
  • BRCA2
  • Breast/ovarian cancer syndrome
  • Cowden syndrome
  • Gene
  • Genetic counseling
  • Genetic risk assessment
  • Hereditary
  • Li-Fraumeni syndrome
  • NCCN Clinical Practice Guidelines

ASJC Scopus subject areas

  • Oncology

Cite this

Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., ... Weitzel, J. N. (2010). Genetic/familial high-risk assessment: Breast and ovarian - Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 8(5), 562-594.

Genetic/familial high-risk assessment : Breast and ovarian - Clinical practice guidelines in oncology™. / Daly, Mary B.; Axilbund, Jennifer E.; Buys, Saundra; Crawford, Beth; Farrell, Carolyn D.; Friedman, Susan; Garber, Judy E.; Goorha, Salil; Gruber, Stephen B.; Hampel, Heather; Kaklamani, Virginia; Kohlmann, Wendy; Kurian, Allison; Litton, Jennifer; Marcom, P. Kelly; Nussbaum, Robert; Offit, Kenneth; Pal, Tuya; Pasche, Boris; Pilarski, Robert; Reiser, Gwen; Shannon, Kristen Mahoney; Smith, Jeffrey R.; Swisher, Elizabeth; Weitzel, Jeffrey N.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 8, No. 5, 05.2010, p. 562-594.

Research output: Contribution to journalArticle

Daly, MB, Axilbund, JE, Buys, S, Crawford, B, Farrell, CD, Friedman, S, Garber, JE, Goorha, S, Gruber, SB, Hampel, H, Kaklamani, V, Kohlmann, W, Kurian, A, Litton, J, Marcom, PK, Nussbaum, R, Offit, K, Pal, T, Pasche, B, Pilarski, R, Reiser, G, Shannon, KM, Smith, JR, Swisher, E & Weitzel, JN 2010, 'Genetic/familial high-risk assessment: Breast and ovarian - Clinical practice guidelines in oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 8, no. 5, pp. 562-594.
Daly, Mary B. ; Axilbund, Jennifer E. ; Buys, Saundra ; Crawford, Beth ; Farrell, Carolyn D. ; Friedman, Susan ; Garber, Judy E. ; Goorha, Salil ; Gruber, Stephen B. ; Hampel, Heather ; Kaklamani, Virginia ; Kohlmann, Wendy ; Kurian, Allison ; Litton, Jennifer ; Marcom, P. Kelly ; Nussbaum, Robert ; Offit, Kenneth ; Pal, Tuya ; Pasche, Boris ; Pilarski, Robert ; Reiser, Gwen ; Shannon, Kristen Mahoney ; Smith, Jeffrey R. ; Swisher, Elizabeth ; Weitzel, Jeffrey N. / Genetic/familial high-risk assessment : Breast and ovarian - Clinical practice guidelines in oncology™. In: JNCCN Journal of the National Comprehensive Cancer Network. 2010 ; Vol. 8, No. 5. pp. 562-594.
@article{ba865b7d559247c1afd27b17bdc5ff43,
title = "Genetic/familial high-risk assessment: Breast and ovarian - Clinical practice guidelines in oncology™",
abstract = "All cancers develop as a result of mutations in certain genes, such as those involved in the regulation of cell growth and/or DNA repair, but not all mutations are inherited. However, family studies have long documented an increased risk for several forms of cancer among first and second-degree relatives . Hereditary cancers are often characterized by mutations associated with a high probability of cancer development, vertical transmission through either mother or father, and an association with other types of tumors. They often have an early age of onset and exhibit an autosomal dominant inheritance pattern. Familial cancers share only some features of hereditary cancers. Although other cancers are associated with these hereditary syndromes, these guidelines mainly focus on management of breast and ovarian cancer risk in these individuals.",
keywords = "BRCA1, BRCA2, Breast/ovarian cancer syndrome, Cowden syndrome, Gene, Genetic counseling, Genetic risk assessment, Hereditary, Li-Fraumeni syndrome, NCCN Clinical Practice Guidelines",
author = "Daly, {Mary B.} and Axilbund, {Jennifer E.} and Saundra Buys and Beth Crawford and Farrell, {Carolyn D.} and Susan Friedman and Garber, {Judy E.} and Salil Goorha and Gruber, {Stephen B.} and Heather Hampel and Virginia Kaklamani and Wendy Kohlmann and Allison Kurian and Jennifer Litton and Marcom, {P. Kelly} and Robert Nussbaum and Kenneth Offit and Tuya Pal and Boris Pasche and Robert Pilarski and Gwen Reiser and Shannon, {Kristen Mahoney} and Smith, {Jeffrey R.} and Elizabeth Swisher and Weitzel, {Jeffrey N.}",
year = "2010",
month = "5",
language = "English (US)",
volume = "8",
pages = "562--594",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "5",

}

TY - JOUR

T1 - Genetic/familial high-risk assessment

T2 - Breast and ovarian - Clinical practice guidelines in oncology™

AU - Daly, Mary B.

AU - Axilbund, Jennifer E.

AU - Buys, Saundra

AU - Crawford, Beth

AU - Farrell, Carolyn D.

AU - Friedman, Susan

AU - Garber, Judy E.

AU - Goorha, Salil

AU - Gruber, Stephen B.

AU - Hampel, Heather

AU - Kaklamani, Virginia

AU - Kohlmann, Wendy

AU - Kurian, Allison

AU - Litton, Jennifer

AU - Marcom, P. Kelly

AU - Nussbaum, Robert

AU - Offit, Kenneth

AU - Pal, Tuya

AU - Pasche, Boris

AU - Pilarski, Robert

AU - Reiser, Gwen

AU - Shannon, Kristen Mahoney

AU - Smith, Jeffrey R.

AU - Swisher, Elizabeth

AU - Weitzel, Jeffrey N.

PY - 2010/5

Y1 - 2010/5

N2 - All cancers develop as a result of mutations in certain genes, such as those involved in the regulation of cell growth and/or DNA repair, but not all mutations are inherited. However, family studies have long documented an increased risk for several forms of cancer among first and second-degree relatives . Hereditary cancers are often characterized by mutations associated with a high probability of cancer development, vertical transmission through either mother or father, and an association with other types of tumors. They often have an early age of onset and exhibit an autosomal dominant inheritance pattern. Familial cancers share only some features of hereditary cancers. Although other cancers are associated with these hereditary syndromes, these guidelines mainly focus on management of breast and ovarian cancer risk in these individuals.

AB - All cancers develop as a result of mutations in certain genes, such as those involved in the regulation of cell growth and/or DNA repair, but not all mutations are inherited. However, family studies have long documented an increased risk for several forms of cancer among first and second-degree relatives . Hereditary cancers are often characterized by mutations associated with a high probability of cancer development, vertical transmission through either mother or father, and an association with other types of tumors. They often have an early age of onset and exhibit an autosomal dominant inheritance pattern. Familial cancers share only some features of hereditary cancers. Although other cancers are associated with these hereditary syndromes, these guidelines mainly focus on management of breast and ovarian cancer risk in these individuals.

KW - BRCA1

KW - BRCA2

KW - Breast/ovarian cancer syndrome

KW - Cowden syndrome

KW - Gene

KW - Genetic counseling

KW - Genetic risk assessment

KW - Hereditary

KW - Li-Fraumeni syndrome

KW - NCCN Clinical Practice Guidelines

UR - http://www.scopus.com/inward/record.url?scp=77952982796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952982796&partnerID=8YFLogxK

M3 - Article

C2 - 20495085

AN - SCOPUS:77952982796

VL - 8

SP - 562

EP - 594

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 5

ER -